Epithelia-mesenchymal transition in breast cancer development

Breast Cancer Research

Volumn 5, Issue 2, 2003, Pages 101-106

  Vincent Salomon, Anne ^a   Thiery, Jean Paul ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast carcinoma; E cadherin; Epithelial mesenchymal transition; Growth factors; Snail

Indexed keywords

DNA; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; NERVE CELL ADHESION MOLECULE; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TRANSCRIPTION FACTOR;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GROWTH; CELL INVASION; CELL LINE; CELL MOTILITY; CYTOLOGY; DNA FINGERPRINTING; DROSOPHILA; GENE TECHNOLOGY; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MESENCHYME; MESENCHYME CELL; METASTASIS; MOLECULAR MECHANICS; MORPHOLOGY; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; EPITHELIUM; EXPERIMENTAL NEOPLASM; MESODERM; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MESODERM; SIGNAL TRANSDUCTION;

EID: 0038700554     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr578     Document Type: Review

References (49)

1. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat 1995, 154:8-20.
2. Veltmaat JM, Orelio CC, Ward-Van Oostwaard D, Van Rooijen MA, Mummery CL, Defize LH: Snail is an immediate early target gene of parathyroid hormone related peptide signaling in parietal endoderm formation. Int J Dev Biol 2000, 44:297-307.
3. Ciruna B, Rossant J: FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 2001, 1:37-49.
4. Nieto MA: The early steps of neural crest development Mech Dev 2001, 105:27-35.
5. Markwald R, Eisenberg C, Eisenberg L, Trusk T, Sugi Y: Epithelial-mesenchymal transformations in early avian heart development. Acta Anat 1996, 156:173-186.
6. Valles AM, Thiery JP, Boyer B: In vitro studies of epithelium-to-mesenchyme transitions. In: Cell Biology: A Laboratory Handbook. Edited by Celis J. New York: Academic Press; 1994:232-242.
7. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
8. Matthay MA, Thiery JP, Lafont F, Stampfer F, Boyer B: Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. J Cell Sci 1993, 106:869-878.
9. Miettinen PJ, Ebner R, Lopez AR, Derynck R: TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994, 127:2021-2036.
10. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E: TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996, 10:2462-2477.
11. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grunert S: Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002, 156:299-313.
12. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP: Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 2001, 98:6686-6691.
13. Oft M, Akhurst RJ, Balmain A: Metastasis is driven by sequential elevation of H-Ras and Smad2 levels. Nat Cell Biol 2002, 4:487-494.
14. Grassi M, Moens G, Rousselle P, Thiery JP, Jouanneau J: The SFL activity secreted by metastatic carcinoma cells is related to laminin 5 and mediates cell scattering in an integrin-independent manner. J Cell Sci 1999, 112:2511-2520.
15. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ: The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001, 128:3117-3131.
16. Wiseman BS, Werb Z: Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
17. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
18. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z: The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146.
19. Sternlicht MD, Bissell MJ, Werb Z: The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000, 19:1102-1113.
20. Elston C, Ellis I: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
21. Tavassoli F: Infiltrating carcinoma: common and familiar special types. In: Pathology of the Breast, edn 4. New York: McGraw-Hill; 1999:401-481.
22. Rosen P: Invasive ductal carcinoma. In: Tumors of the Mammary Gland. Washington DC: Armed Forces Institute of Pathology; 1992:157-168.
23. Rosen P: Invasive duct carcinoma: assessment of prognosis, morphologic pronostic markers and tumor growth rate. In: Rosen's Breast Pathology: Philadelphia: Lippincott, Williams and Wilkins; 2001:1004.
24. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P: Infiltrating lobular carcinoma of the breast Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996, 77:113-120.
25. Ellis I, Galea M, Broughton N, Locker A, Blamey R, Elston C: Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992, 20:479-489.
26. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, Travagli JP, Gadenne C, Friedman S: Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988, 61:2503-2510.
27. Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994, 1198:11-26.
28. Wheelock MJ, Soler AP, Knudsen KA: Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001, 6:275-285.
29. Berx G, Becker KF, Hofler H, van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998, 12:226-237.
30. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY: Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001, 20:3814-3823.
31. Leptin M: twist and snail as positive and negative regulators during Drosophila mesoderm development. Genes Dev 1991, 5:1568-1576.
32. Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002, 3:155-166.
33. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83.
34. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7:1267-1278.
35. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA: Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21:3241-3246.
36. Hajra KM, Chen DY, Fearon ER: The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62:1613-1618.
37. Braun S, Pantel K: Biological characteristics of micrometastetic cancer cells in bone marrow. Cancer Metastasis Rev 1999, 18:75-90.
38. Ilyas M: Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis? J Pathol 2000, 190:3-5.
39. Bukholm IK, Nesland JM, Borresen-Dale AL: Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. J Pathol 2000, 190:15-19.
40. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000, 148:779-790.
41. Niemann C, Brinkmann V, Spitzer E, Hartmann G, Sachs M, Naundorf H, Birchmeier W: Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol 1998, 143:533-545.
42. Kim JB, Islam S, Kim YJ, Prudoff RS, Sass KM, Wheelock MJ, Johnson KR: N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 2000, 151:1193-1206.
43. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, Birchmeier W: Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002, 4:222-231.
44. O'Brien LE, Zegers MM, Mostov KE: Opinion. Building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol 2002, 3:531-537.
45. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein-Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
46. Deugnier MA, Teuliere J, Faraldo MM, Thiery JP, Glukhova M: The importance of being a myoepithelial cell. Breast Cancer Res 2002, 4:224-230.
47. Deugnier MA, Faraldo MM, Janji B, Rousselle P, Thiery JP, Glukhova MA: EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties. J Cell Biol 2002, 159:453-463.
48. Petersen OW, Lind Nielsen H, Gudjonsson T, Villadsen R, Ronnov-Jessen L, Bissell MJ: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001, 3:213-217.
49. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.